Powis, Garth <br/><br/>
Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.  [electronic resource] 

 -  Molecular cancer therapeutics  Mar 2006 
 - 630-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-05-0487  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Line, Tumor<br/>Dioxanes--chemistry<br/>Enzyme Inhibitors--pharmacology<br/>Glycine--analogs & derivatives<br/>Humans<br/>Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors<br/>Mice<br/>Naphthalenes<br/>Neoplasms--enzymology<br/>Spiro Compounds--chemistry<br/>Thioredoxin Reductase 1<br/>Thioredoxin-Disulfide Reductase--antagonists & inhibitors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays